Neumora Therapeutics, Inc.
NMRA
$2.28
$0.052.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -20.48% | -18.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.48% | -23.82% | |||
| Operating Income | 2.48% | 23.82% | |||
| Income Before Tax | -7.68% | 22.36% | |||
| Income Tax Expenses | -- | -76.19% | |||
| Earnings from Continuing Operations | -7.63% | 22.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.63% | 22.45% | |||
| EBIT | 2.48% | 23.82% | |||
| EBITDA | 2.49% | 23.68% | |||
| EPS Basic | -7.54% | 22.56% | |||
| Normalized Basic EPS | 1.87% | 22.49% | |||
| EPS Diluted | -7.54% | 22.56% | |||
| Normalized Diluted EPS | 1.87% | 22.49% | |||
| Average Basic Shares Outstanding | 0.09% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.09% | 0.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||